Ocuvir 800 DT Tablet contains Acyclovir 800 mg, an antiviral agent indicated for the treatment of infections caused by herpes viruses, including herpes simplex virus types 1 and 2, varicella-zoster virus, and other susceptible viral infections. Acyclovir acts by inhibiting viral DNA synthesis, thereby preventing viral replication and reducing the severity and duration of infection. Ocuvir 800 DT is formulated as a dispersible tablet, allowing for rapid dissolution and ease of administration, particularly beneficial for patients with difficulty swallowing conventional tablets. This medication is commonly prescribed for the management of herpes simplex encephalitis, genital herpes, herpes labialis, and shingles (herpes zoster). It is also used prophylactically in immunocompromised patients to prevent viral reactivation. The recommended dosage and duration of therapy depend on the type and severity of infection, as well as patient-specific factors such as renal function. Ocuvir 800 DT should be taken as directed by a healthcare professional, with adequate hydration to minimize the risk of nephrotoxicity. Common adverse effects include headache, nausea, and gastrointestinal discomfort. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. This medication is contraindicated in individuals with known hypersensitivity to acyclovir or valacyclovir.